Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease
Crossref DOI link: https://doi.org/10.1007/s40268-016-0158-4
Published Online: 2017-01-06
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gryka, Rebecca J.
Buckley, Leo F.
Anderson, Sarah M.
License valid from 2017-01-06